Apimeds Pharmaceuticals US, Inc. (APUS) Insider Trading

Name: Apimeds Pharmaceuticals US, Inc. (APUS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Nov 13, 2025): Weintraub Bennett (Director): Grant/Award of 10,000 shares.

Get alerted when insiders trade APUS

Email address

Loading company data...

Loading company details...